Filing Flows › Microvision (MVIS) › Q2 2026 › vs Q2 2025
Microvision (MVIS) Q2 2026 vs Q2 2025 (year over year)
Microvision's revenue rose $1.3M (+850%) from $155K in Q2 2025 to $1.5M in Q2 2026. The biggest changes: Product Revenue +$1.1M (32×); Contract Revenue +$314K (+785%); License and Royalty Revenue −$63K (-78%).
Microvision, Q2 2026: revenue $1.5M (+850% year over year), net loss $36.9M, operating cash flow −$19.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product Revenue | $1.1M | $34K | $1.1M | 32× |
| Contract Revenue | $354K | $40K | $314K | +785% |
| License and Royalty Revenue | $18K | $81K | −$63K | -78% |
| Revenue | $1.5M | $155K | $1.3M | +850% |
| Net loss | $36.9M | $14.2M | $22.7M | +160% |
| Costs & expenses | $38.4M | $14.9M | $23.5M | +158% |
| Operating costs | $25.7M | $14.8M | $10.9M | +73% |
| Interest & other, net | $12.6M | −$520K | $13.1M | — |
| Income tax | $181K | $93K | $88K | +95% |
| Cost of revenue | $831K | $716K | $115K | +16% |
| Research & development | $15.7M | $7.7M | $8.0M | +105% |
| SG&A | $9.2M | $6.4M | $2.8M | +43% |
| Operating cash sources | $36.9M | $14.2M | $22.7M | +160% |
| Depreciation & amortization | $3.0M | $1.5M | $1.4M | +93% |
| Share-based compensation | $1.3M | $1.9M | −$626K | -32% |
| Working capital & other | $13.5M | −$2.0M | $15.5M | — |
| Cash used in operations | $19.1M | $12.7M | $6.4M | +50% |
| Net loss absorbed | $36.9M | $14.2M | $22.7M | +160% |
Questions
How much did Microvision's revenue grow year over year in Q2 2026?
Microvision's revenue rose $1.3M (+850%) from $155K in Q2 2025 to $1.5M in Q2 2026.
What drove Microvision's revenue change in Q2 2026?
Product Revenue +$1.1M (32×); Contract Revenue +$314K (+785%); License and Royalty Revenue −$63K (-78%).